Sort by
Refine Your Search
-
Category
-
Country
-
Program
-
Employer
- Northeastern University
- City of Hope
- Duke University
- Indiana University
- University of Miami
- University of Pennsylvania
- University of Texas Health Science Center San Antonio
- University of Washington
- Yale University
- Cedars Sinai Medical Center
- Columbia University
- FUNDACIO INSTITUT D'INVESTIGACIO EN CIENCIES DE LA SALUT GERMANS TRIAS I PUJOL
- Newcastle University;
- SUNY
- UNIVERSITY OF HELSINKI
- University of California
- University of Colorado
- University of Glasgow
- University of Maryland, Baltimore
- University of Nevada, Reno
- University of Newcastle
- University of Pittsburgh
- 12 more »
- « less
-
Field
-
and communication skills to join an international, multidisciplinary team working in the area of neuromuscular diseases. Based at the John Walton Muscular Dystrophy Research Centre (JWMDRC) at Newcastle
-
schemes and a number of health and wellbeing initiatives to support you. Closing Date: 19 October 2026 The Role You will join the John Walton Muscular Dystrophy Research Centre, an internationally
-
Lateral Sclerosis (ALS) and neuromuscular disorders associated with the Muscular Dystrophy Association (MDA). This role coordinates multidisciplinary care, facilitates patient access to services, ensures
-
, primary membranous nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes, generalized myasthenia gravis, and myotonic dystrophy type 1. Vertex was founded in 1989 and has its global
-
, neuropathic pain, APOL1-mediated kidney disease, primary membranous nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes, generalized myasthenia gravis, and myotonic dystrophy type 1
-
, including IgA nephropathy, neuropathic pain, APOL1-mediated kidney disease, primary membranous nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes, and myotonic dystrophy type 1. Vertex
-
, primary membranous, nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes, and myotonic dystrophy type 1. Vertex was founded in 1989 and has its global headquarters in Boston, with
-
-mediated kidney disease, primary membranous nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes, generalized myasthenia gravis, and myotonic dystrophy type 1. Vertex was founded in
-
myotonic dystrophy type 1. Vertex was founded in 1989 and has its global headquarters in Boston, with international headquarters in London. Additionally, the company has research and development sites and
-
, primary membranous nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes and myotonic dystrophy type 1. Vertex was founded in 1989 and has its global headquarters in Boston, with